Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,501.65 -12.72 -0.08%
S&P 500 1,875.39 -4.16 -0.22%
NASDAQ 4,126.97 -34.49 -0.83%
Ticker Volume Price Price Delta
STOXX 50 3,196.95 20.98 0.66%
FTSE 100 6,723.35 48.61 0.73%
DAX 9,580.23 36.04 0.38%
Ticker Volume Price Price Delta
NIKKEI 14,404.99 -141.28 -0.97%
TOPIX 1,164.90 -8.91 -0.76%
HANG SENG 22,562.80 53.16 0.24%

Epocrates Helped Physicians Avoid 27 Million Drug Errors in 2012



Epocrates Helped Physicians Avoid 27 Million Drug Errors in 2012

One in Four Drug Lookups Credited With Preventing an Adverse Event

SAN MATEO, Calif., Jan. 23, 2013 (GLOBE NEWSWIRE) -- Patient safety is a top
priority for all clinicians, yet preventable drug errors are still prevalent
throughout the United States. In the past year, Epocrates (Nasdaq:EPOC) has
helped clinicians avoid more than 27 million adverse drug events through its
popular medical application. This translates to more than 25 percent of
Epocrates drug lookups preventing a minor to serious adverse drug event.

Sixty percent of U.S. physicians who use the Epocrates app reported avoiding
at least one adverse drug error every week through the company's mobile and
online reference products, according to a recent survey^1. Physicians cite the
drug Interaction Checker as the most helpful safety feature in the Epocrates
app and a primary influence in changing prescribing decisions. The Interaction
Checker enables clinicians to quickly enter up to 30 prescription,
over-the-counter and alternative medicines to view potential interactions in
order of severity. Additional safety features in the app include drug dosing,
adverse reactions and news alerts.

"Epocrates delivers invaluable information at my fingertips with access to
prescribing information when and where I need it," said Dr. W. Wolfe,
Spotsylvania, Va. "The product has made my treatment of patients safer. I
would find it more difficult to practice medicine without Epocrates, given the
increasing complexities of medicine."

With drug information changing at a rapid pace, it is important for physicians
to have information readily available at the point of care. In 2012, the Food
and Drug Administration (FDA) approved 35 new prescription medications, one of
the highest authorization levels in history. As more drugs join the market,
new indications are approved and the average patient is taking multiple
medications, physicians need easy access to trusted medication safety
information instantly.

"Epocrates is a very valuable tool for me as someone with chronic illness on
multiple medications. I need to closely monitor for potential interactions
with my physician and can immediately review results together on a
smartphone," said John Chaney, Pikeville, Ky.

The majority of U.S. physicians currently use a mobile device, such as a
smartphone, tablet or combination of both, to access Epocrates. Most
physicians who use the app access it daily, primarily during patient
encounters. Epocrates products are available on popular platforms such as
Apple iOS and Google Android OS. For more information and to download the app,
visit www.epocrates.com/mobile.

About Epocrates, Inc.

Epocrates, Inc. (Nasdaq:EPOC) is recognized for developing the #1 medical
application among U.S. physicians for clinical content, practice tools and
health industry engagement at the point of care. Epocrates has established a
loyal network of more than one million healthcare professionals, including 50
percent of U.S. physicians, who routinely use its intuitive solutions to help
streamline workflow and improve patient care. The company also facilitates the
delivery of valuable content and tools between partnering organizations and
its members. For more information, please visit www.epocrates.com/company. 

The Epocrates, Inc. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=10943

Epocrates is a trademark of Epocrates, Inc., registered in the U.S. and other
countries.

^1 2012 Epocrates Specialty Survey (n= 2,700 U.S. physicians). Results are
available at: http://www.epocrates.com/who/media/mediaresources/statistics.

CONTACT: Erica Sniad Morgenstern
         Senior Director, Public Relations and Communications
         Epocrates, Inc.
         (650) 227-6907
         pr@epocrates.com

Epocrates, Inc. Logo
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement